Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Patrick R. O'neil

General Counsel at Ionis Pharmaceuticals Inc (IONS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $9.2M

Reported trades

Filed Stock Type Shares Price Value Since
Jun 30SEC IONSIonis Pharmaceuticals Inc Sell Plan 3,06961,470 held (−5%) $80.00 $246K -43.4%
Mar 11SEC IONSIonis Pharmaceuticals Inc Sell Plan 10,14862,211 held (−14%) $75.25 $764K -39.8%
Feb 2SEC IONSIonis Pharmaceuticals Inc Sell 6,17971,983 held (−8%) $83.53 $516K -45.8%
Jan 20SEC IONSIonis Pharmaceuticals Inc Sell 9,19166,171 held (−12%) $75.84 $697K -40.3%
Oct 8SEC IONSIonis Pharmaceuticals Inc Sell Plan 10,20057,130 held (−15%) $69.89 $713K -35.2%
Oct 8SEC IONSIonis Pharmaceuticals Inc Sell Plan 3,24153,889 held (−6%) $69.27 $225K -34.6%
Oct 2SEC IONSIonis Pharmaceuticals Inc Sell Plan 30,20357,130 held (−35%) $67.69 $2.0M -33.1%
Oct 2SEC IONSIonis Pharmaceuticals Inc Sell Plan 34,46157,130 held (−38%) $67.69 $2.3M -33.1%
Oct 1SEC IONSIonis Pharmaceuticals Inc Sell Plan 10,47357,130 held (−15%) $64.54 $676K -29.8%
Oct 1SEC IONSIonis Pharmaceuticals Inc Sell Plan 14,82757,130 held (−21%) $64.68 $959K -30.0%
  • Sell

    General Counsel Patrick R. O'neil sold $246K of IONS at $80.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Patrick R. O'neil sold $764K of IONS at $75.25 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Patrick R. O'neil sold $713K of IONS at $69.89 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Patrick R. O'neil sold $225K of IONS at $69.27 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Patrick R. O'neil sold $2.0M of IONS at $67.69 — cuts the stake by 35%; pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Patrick R. O'neil sold $2.3M of IONS at $67.69 — cuts the stake by 38%; pre-scheduled 10b5-1 plan sale.